These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 11809688

  • 21. Intestinal immune responses in wild-type and Apcmin/+ mouse, a model for colon cancer.
    Kettunen HL, Kettunen AS, Rautonen NE.
    Cancer Res; 2003 Aug 15; 63(16):5136-42. PubMed ID: 12941845
    [Abstract] [Full Text] [Related]

  • 22. Effects of selective PGE2 receptor antagonists in esophageal adenocarcinoma cells derived from Barrett's esophagus.
    Piazuelo E, Jiménez P, Strunk M, Santander S, García A, Esteva F, Lanas A.
    Prostaglandins Other Lipid Mediat; 2006 Dec 15; 81(3-4):150-61. PubMed ID: 17085323
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model.
    Narayanan BA, Narayanan NK, Pittman B, Reddy BS.
    Clin Cancer Res; 2004 Nov 15; 10(22):7727-37. PubMed ID: 15570007
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Stimulation of renin release by prostaglandin E2 is mediated by EP2 and EP4 receptors in mouse kidneys.
    Schweda F, Klar J, Narumiya S, Nüsing RM, Kurtz A.
    Am J Physiol Renal Physiol; 2004 Sep 15; 287(3):F427-33. PubMed ID: 15113745
    [Abstract] [Full Text] [Related]

  • 27. Characterization of EP receptor subtypes responsible for prostaglandin E2-induced pain responses by use of EP1 and EP3 receptor knockout mice.
    Minami T, Nakano H, Kobayashi T, Sugimoto Y, Ushikubi F, Ichikawa A, Narumiya S, Ito S.
    Br J Pharmacol; 2001 Jun 15; 133(3):438-44. PubMed ID: 11375261
    [Abstract] [Full Text] [Related]

  • 28. Chemoprevention of familial adenomatous polyposis by low doses of atorvastatin and celecoxib given individually and in combination to APCMin mice.
    Swamy MV, Patlolla JM, Steele VE, Kopelovich L, Reddy BS, Rao CV.
    Cancer Res; 2006 Jul 15; 66(14):7370-7. PubMed ID: 16849589
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. EP2/EP4 signalling inhibits monocyte chemoattractant protein-1 production induced by interleukin 1beta in synovial fibroblasts.
    Largo R, Díez-Ortego I, Sanchez-Pernaute O, López-Armada MJ, Alvarez-Soria MA, Egido J, Herrero-Beaumont G.
    Ann Rheum Dis; 2004 Oct 15; 63(10):1197-204. PubMed ID: 15361371
    [Abstract] [Full Text] [Related]

  • 32. The sulfide metabolite of sulindac prevents tumors and restores enterocyte apoptosis in a murine model of familial adenomatous polyposis.
    Mahmoud NN, Boolbol SK, Dannenberg AJ, Mestre JR, Bilinski RT, Martucci C, Newmark HL, Chadburn A, Bertagnolli MM.
    Carcinogenesis; 1998 Jan 15; 19(1):87-91. PubMed ID: 9472698
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Prostaglandin E(2)-EP(3) signaling suppresses skin inflammation in murine contact hypersensitivity.
    Honda T, Matsuoka T, Ueta M, Kabashima K, Miyachi Y, Narumiya S.
    J Allergy Clin Immunol; 2009 Oct 15; 124(4):809-18.e2. PubMed ID: 19541354
    [Abstract] [Full Text] [Related]

  • 35. Inhibition of chemically induced skin carcinogenesis by sulindac is independent of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta).
    Kim DJ, Prabhu KS, Gonzalez FJ, Peters JM.
    Carcinogenesis; 2006 May 15; 27(5):1105-12. PubMed ID: 16418176
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Involvement of cyclooxygenase-1, prostaglandin E2 and EP1 receptors in acid-induced HCO3- secretion in stomach.
    Takeuchi K, Aihara E, Sasaki Y, Nomura Y, Ise F.
    J Physiol Pharmacol; 2006 Dec 15; 57(4):661-76. PubMed ID: 17229989
    [Abstract] [Full Text] [Related]

  • 39. PGE(2) receptor EP1 renders dopaminergic neurons selectively vulnerable to low-level oxidative stress and direct PGE(2) neurotoxicity.
    Carrasco E, Casper D, Werner P.
    J Neurosci Res; 2007 Nov 01; 85(14):3109-17. PubMed ID: 17868147
    [Abstract] [Full Text] [Related]

  • 40. Cyclooxygenase-2 (COX-2) inhibitors sensitize tumor cells specifically to death receptor-induced apoptosis independently of COX-2 inhibition.
    Totzke G, Schulze-Osthoff K, Jänicke RU.
    Oncogene; 2003 Sep 11; 22(39):8021-30. PubMed ID: 12970750
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.